Sclerostin, an osteocytes-derived bone-forming inhibitor

Krzysztof H Włodarski1, Ryszard Galus, Aniela Brodzikowska

  • 1Department of Histology and Embryology, Medical University of Warsaw, Warsaw, Poland. krzysztof.wlodarski@wum.edu.pl

Insights

Sclerostin, a protein made by osteocytes, inhibits bone formation by blocking Wnt signaling. Reducing sclerostin, through mechanical loading or antibodies, promotes bone growth and may treat osteoporosis.

Area of Science:

  • Bone biology
  • Cell signaling
  • Osteoporosis research

Background:

  • Sclerostin is a glycoprotein produced by osteocytes.
  • It acts as a potent inhibitor of osteoblast proliferation and differentiation.
  • Sclerostin negatively regulates the Wnt signaling pathway, crucial for osteoblast activity.

Purpose of the Study:

  • To explain the mechanism by which mechanical loading stimulates bone formation.
  • To highlight the role of sclerostin in bone metabolism.
  • To introduce sclerostin-targeting monoclonal antibodies as a therapeutic strategy for osteoporosis.

Main Methods:

  • Investigated the role of sclerostin in osteocyte-osteoblast communication.
  • Examined the effect of mechanical loading on sclerostin synthesis.
  • Reviewed the impact of monoclonal antibodies against sclerostin on bone remodeling.

Main Results:

  • Mechanical loading reduces osteocyte sclerostin synthesis, thereby activating Wnt signaling and promoting osteoblast bone-forming activity.
  • Sclerostin directly inhibits osteoblast proliferation and differentiation.
  • Monoclonal antibodies against sclerostin counteract sclerostin's bone-catabolic effects.

Conclusions:

  • Sclerostin is a key mediator linking mechanical stimuli to bone formation.
  • Targeting sclerostin with monoclonal antibodies offers a promising therapeutic approach for osteoporosis by enhancing bone formation.

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Cells and Tissue01:30

Bone Cells and Tissue

Bones contain a relatively small number of cells entrenched in a matrix of organic and inorganic components. Although bone cells compose only a small amount of the bone volume, they are crucial to its function. Four types of cells are found within the bone tissue— osteoblasts, osteocytes, osteogenic cells, and osteoclasts.
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the periosteum and...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.